Status:
COMPLETED
Occult Obscure Gastrointestinal Bleeding
Lead Sponsor:
Blymum Srl
Conditions:
Gastrointestinal Bleeding
Eligibility:
All Genders
55-65 years
Phase:
NA
Brief Summary
To test the activity of a polyglucosamine (PG) together with a Standard Management protocol (SM) on the occult and obscure gastrointestinal bleeding (OGIB) and the clinical symptoms in patients suffer...
Detailed Description
The trial was conducted in a single center and subjects were participating to the San Valentino Vascular Screening Project (SVVSP). Sixty patients with history of colonic diverticulitis (CD) and occul...
Eligibility Criteria
Inclusion
- Subjects aged between 55 to 65 years (males and females).
- CD diagnosis.
- DICA (Diverticular Inflammation and Complication Assessment) class DICA 2 or DICA 3.
- OGIB positive to Hemoccult Sensa Fecal Occult Blood Procedure.
Exclusion
- Subjects with Class DICA \> 3.
- Therapy with mesalazine antibiotics and probiotics.
- Cancer of any type (a part from benign polyposis),
- Alcoholism.
- Parkinsonism.
- Alzheimer's Disease.
- Severe depression.
- Drug addiction.
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03464539
Start Date
February 1 2017
End Date
June 15 2017
Last Update
April 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spoltore - Pescara
Pescara, Italy